Cerivastatin, a new synthetic HMG CO-A reductase inhibitor in the treatment of patients with primary hyperlipidaemia

被引：0
|
作者：
Kukharchuk, VV [1 ]
Solovieva, EY [1 ]
Rozhkova, TA [1 ]
Tvorogova, MG [1 ]
机构：
[1] Cardiol Res Ctr, Inst Clin Cardiol, Moscow, Russia
来源：
ATHEROSCLEROSIS | 1999年 / 144卷
关键词：
D O I：
10.1016/S0021-9150(99)80751-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：196 / 197
页数：2
相关论文
共 50 条
  • [1] HYPOMETHYLATION OF HMG CO-A REDUCTASE GENE (HMG CO-A RG) IN HUMAN COLON CARCINOGENESIS
    VASUDEVAN, S
    KHANDELWAL, M
    AKERMAN, PA
    JONES, WF
    RAO, PM
    RAJALAKSHMI, S
    MARCON, NE
    SARMA, DSR
    [J]. GASTROENTEROLOGY, 1994, 106 (04) : A448 - A448
  • [2] Cerivastatin, a new potent HMG-CoA reductase inhibitor: Efficacy and tolerability in primary hypercholesterolemia
    Insull, W
    Stein, E
    Whalen, E
    Ripa, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 92192 - 92192
  • [3] Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor
    Bischoff, H
    Angerbauer, R
    Bender, J
    Bischoff, E
    Faggiotto, A
    Petzinna, D
    Pfitzner, J
    Porter, MC
    Schmidt, D
    Thomas, G
    [J]. ATHEROSCLEROSIS, 1997, 135 (01) : 119 - 130
  • [4] A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia
    Sasaki, J
    Arakawa, K
    Yamamoto, K
    Kobori, S
    Ageta, M
    Kono, S
    [J]. CLINICAL THERAPEUTICS, 1998, 20 (03) : 539 - 548
  • [5] The HMG Co-A reductase inhibitors ('statins') and myotoxic effects
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2002, 92 (08): : 596 - 597
  • [6] TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA WITH SYNVINOLIN - NEW HMG COA REDUCTASE INHIBITOR
    STEIN, EA
    LAMKIN, GE
    OLIVERA, EH
    BEWLEY, DZ
    [J]. ARTERIOSCLEROSIS, 1987, 7 (05): : A514 - A515
  • [7] A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia.
    Sasaki, J
    Arakawa, K
    Yamamoto, K
    Kobori, S
    Ageta, M
    Kono, S
    [J]. REVUE DE MEDECINE INTERNE, 1999, 20 : 393S - 398S
  • [8] Prehospital HMG Co-A reductase inhibitor use and reduced mortality in hemorrhagic shock due to trauma
    Feeney, J. M.
    Jayaraman, V.
    Spilka, J.
    Shapiro, D. S.
    Ellner, S.
    Marshall, W. T., III
    Jacobs, L. M.
    [J]. EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 2012, 38 (02) : 171 - 176
  • [9] Prehospital HMG Co-A reductase inhibitor use and reduced mortality in hemorrhagic shock due to trauma
    J. M. Feeney
    V. Jayaraman
    J. Spilka
    D. S. Shapiro
    S. Ellner
    W. T. Marshall
    L. M. Jacobs
    [J]. European Journal of Trauma and Emergency Surgery, 2012, 38 : 171 - 176
  • [10] Prehospital HMG Co-A Reductase Inhibitor Use and Reduced Mortality in Ruptured Abdominal Aortic Aneurysm
    Feeney, James M.
    Burns, Karyl
    Staff, Ilene
    Bai, Jilin
    Rodrigues, Natercia
    Fortier, Jill
    Jacobs, Lenworth M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (01) : 41 - 46
12345